Table 3.
Univariate |
Multivariate |
|||
---|---|---|---|---|
HR (95% CI) | P-value | HR (95% CI) | P-value | |
Age | 1.04 (1.02–1.06) | 0.000 | 1.02 (1.01–1.04) | 0.042 |
Sex | 1.58 (1.07–2.37) | 0.026 | 1.17 (0.72–1.91) | 0.528 |
Cardiac involvement | 2.42 (1.26–4.01) | 0.000 | 1.71 (1.08–2.69) | 0.022 |
Liver involvement | 2.73 (1.73–4.30) | 0.000 | 2.27 (1.34–3.83) | 0.002 |
Hypotension | 2.08 (1.43–3.02) | 0.000 | 1.09 (0.69–1.71) | 0.698 |
Serum creatinine | 1.35 (1.19–1.52) | 0.000 | 1.15 (0.96–1.36) | 0.125 |
The proportion of bone marrow plasma cells | 1.12 (1.07–1.18) | 0.000 | 1.08 (1.04–1.12) | 0.012 |
Special treatment | 0.41 (0.28–0.60) | 0.000 | 0.39 (0.24–0.58) | 0.000 |
Disease duration | 0.99 (0.98–1.01) | 0.772 | ||
Involved serum free light chains | 1.05 (0.99–1.10) | 0.087 | ||
Proteinuria | 1.03 (0.99–1.13) | 0.057 | ||
Total cholesterol | 1.01 (0.96–1.06) | 0.730 | ||
Serum albumin | 0.96 (0.93–1.03) | 0.064 | ||
Globulin | 0.98 (0.95–1.02) | 0.357 | ||
Ejection fraction | 0.88 (0.74–1.18) | 0.115 | ||
Interventricular septum | 1.01 (0.92–1.09) | 0.917 | ||
Abnormal alkaline phosphatase | 2.13 (0.91–4.17) | 0.075 | ||
Hemoglobin | 0.96 (0.88–1.05) | 0.332 | ||
Involved organs ≥2 | 1.32 (0.78–1.89) | 0.233 |